Patents by Inventor Maureen D. Donovan

Maureen D. Donovan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7687475
    Abstract: The present invention is directed to small interfering RNA molecules targeted against a gene of interest in respiratory epithelial cells, and methods of using these RNA molecules.
    Type: Grant
    Filed: October 16, 2007
    Date of Patent: March 30, 2010
    Assignee: University of Iowa Research Foundation
    Inventors: Paul B. McCray, Beverly L. Davidson, Anthony J. Fischer, Hong P. Jia, Maureen D. Donovan, Patrick L. Sinn, Mark Aaron Behlke
  • Publication number: 20090029934
    Abstract: The present invention is directed to small interfering RNA molecules targeted against a gene of interest in respiratory epithelial cells, and methods of using these RNA molecules.
    Type: Application
    Filed: October 16, 2007
    Publication date: January 29, 2009
    Inventors: Paul B. McCray, Beverly L. Davidson, Anthony J. Fischer, Hong P. Jia, Maureen D. Donovan, Patrick L. Sinn, Mark Aaron Behlke
  • Patent number: 7297786
    Abstract: The present invention is directed to small interfering RNA molecules targeted against a gene of interest in respiratory epithelial cells, and methods of using these RNA molecules.
    Type: Grant
    Filed: July 11, 2005
    Date of Patent: November 20, 2007
    Assignee: University of Iowa Research Foundation
    Inventors: Paul B. McCray, Beverly L. Davidson, Anthony J. Fischer, Hong P. Jia, Maureen D. Donovan, Patrick L. Sinn, Mark Aaron Behlke
  • Publication number: 20020155066
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: February 4, 2002
    Publication date: October 24, 2002
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Patent number: 6348209
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: February 19, 2002
    Assignee: Battelle Pulmonary Therapeutics, Inc.
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Jr., Maureen D. Donovan
  • Publication number: 20010038827
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Publication number: 20010038826
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 8, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan
  • Publication number: 20010036444
    Abstract: A formulation, method, and apparatus for treating neoplasms such as cancer by administering a pharmaceutically effective amount of highly toxic composition by inhalation, wherein the composition is a non-encapsulated antineoplastic drug.
    Type: Application
    Filed: June 6, 2001
    Publication date: November 1, 2001
    Inventors: Michael E. Placke, Anthony R. Imondi, Michael J. Brooker, John E. Frye, Praful K. Shah, Douglas R. Flanagan, Maureen D. Donovan